CIK 0001847367
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
ALUMIS INC.
Sign in to watch- Ticker
- ALMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 650-231-6625
- Business address
- 280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- FL2021-001, Inc.
- Open-market buys, last 90 days
- $10,726,255
- in 1 filing
- Open-market sales, last 90 days
- $1,037,650
- in 7 filings
Net +$9,688,605. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- AKKARAJU SRINIVAS +$9.7M Director sold 4% of stake
- Schroer John R. −$5K Chief Financial Officer sold 3% of stake
- Hardiman Roy C. −$4K Chief Business & Strategy Ofcr sold <1% of stake
- Goldstein David M −$4K Chief Scientific Officer sold 2% of stake
- Bradley Mark Christopher −$4K Chief Development Officer sold 1% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-02 | Schroer John R. Chief Financial Officer | Sale | −794 | $6.52 | $5K | 23,924 |
| 2026-08-03 | Schroer John R. Chief Financial Officer | Sale | −3,282 | $26.37 | $87K | 24,718 |
| 2026-01-26 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +202,225 | 202,225 | ||
| 2025-07-29 | Schroer John R. Chief Financial Officer | Grant or award | +28,000 | 28,000 | ||
| 2025-07-29 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +111,950 | 111,950 | ||
| 2025-02-18 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −17,112 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +17,112 | 17,112 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −171,122 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +171,122 | 171,122 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −64,171 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +64,171 | 64,171 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −12,834 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +12,834 | 12,834 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −17,171 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +17,171 | 17,171 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −59,516 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +59,516 | 59,516 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Returned to the company · Stock Option (Right to Buy) | −55,978 | 0 | ||
| 2024-07-01 | Schroer John R. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +55,978 | 55,978 |
Page 1 of 2 · 23 trades